LDS/Medical Tests/Beta-Catenin (CTNNB1) Mutation Analysis

Beta-Catenin (CTNNB1) Mutation Analysis

The CTNNB1 gene located in the short (p) arm of chromosome 3 at position 22.1 encodes beta-catenin. β-catenin is a dual function protein, involved in regulation and coordination of cell-cell adhesion and gene transcription. The beta-catenin protein is also involved in cell signaling as an essential part of the Wnt signaling pathway. Among its many activities, beta-catenin appears to play an important role in the normal function of hair follicles. This protein is active in cells that make up the follicle matrix. Alterations in the localization and expression levels of beta-catenin have been associated with various forms of heart disease, including dilated cardiomyopathy. Somatic mutations in the CTNNB1 gene are associated with many cancers, including desmoids tumors, adrenal cortical carcinoma, biliary tract adenocarcinoma, medulloblastoma, endometrial adenocarcinoma, ovarian endometroid carcinoma, diffuse large B-cell lymphoma, NK-T cell lymphoma, Wilms tumor, hepatocellular carcinoma, pancreatic tumors, pituitary craniopharyngioma, salivary gland basal cell adenoma, malignant melanoma, intestinal adenocarcinoma, and, papillary and anaplastic carcinoma of thyroid. These gain-of-function mutations in the CTNNB1 gene prevent the breakdown of beta-catenin when it is no longer needed and allows the protein to accumulate within cells. The excess beta-catenin moves into the cell nucleus and promotes the unchecked proliferation of cells, allowing cancerous tumors to develop.

Desmoid tumors are low-grade tumors that are generally highly invasive and locally aggressive, but do not metastasize. They are rare tumors with an estimated incidence of 2 to 4 cases per million inhabitants per year. They arise primarily in the extremities and the trunk wall, followed by the abdominal wall and the abdominal cavity. Wilms tumor is a rare form of kidney cancer that occurs almost exclusively in children. CTNNB1 gene mutations in Wilms tumor result in an overly active protein. This active beta-catenin protein promotes longer than normal Wnt signaling, which leads to the unchecked proliferation of kidney cells and tumor development.

  • As an aid in diagnosis of desmoid tumors and predicting prognosis
  • To differentiate desmoid tumor from other soft tissue tumors
  • As an aid in diagnosis of Wilms tumor
Mutation or pathogenic variant in CTNNB1 gene in codon 41 and 45 is common in desmoid tumors. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.

Negative for mutation or pathogenic variant in CTNNB1 gene

Sequence analysis by bidirectional sequence analysis CTNNB1 gene targeted deletion/duplication analysis by quantitative multiplex PCR, long-range PCR, multiplex ligation dependent probe amplification (MLPA), Next generation sequencing.

Formalin-fixed paraffin-embedded tissue block.

Stability

  • Ambient: Indefinitely
  • Refrigerated: Indefinitely
  • Frozen: Unacceptable
Electrophoresis, immunohistochemistry, H/E stain, complete blood count (CBC), Bone marrow aspiration and biopsy, Fine needle aspiration (FNA) biopsy, Excisional or incisional biopsy, Flow cytometry, CT-guided needle biopsy, PET scan, endoscopy, liver function tests, FISH, Karyotyping.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login